急性髓细胞白血病1蛋白抗体

英文名称    RUNX1    

中文名称    急性髓细胞白血病1蛋白抗体    

别    名    Acute myeloid leukemia 1; Acute myeloid leukemia 1 protein; alpha subunit core binding factor; AML 1; AML1 EVI 1; Aml1 oncogene; AMLCR 1; AMLCR1; CBFA 2; CBFA2; Core binding factor alpha 2 subunit; Core binding factor runt domain alpha subunit 2; EVI 1; EVI1; HGNC; Oncogene AML 1; PEA2 alpha; PEBP2 alpha B; PEBP2A2; PEBP2aB; Polyomavirus enhancer binding protein 2 alpha B subunit; Run1; Runt related transcription factor 1; RUNX 1; SL3 3 enhancer factor 1 alpha B subunit; SL3/AKV core binding factor alpha B subunit; RUNX1_HUMAN.    

急性髓细胞白血病1蛋白抗体        

说 明 书    0.1ml  0.2ml      

研究领域    肿瘤  心血管  细胞生物  细胞凋亡      

抗体来源    Rabbit    

克隆类型    Polyclonal    

交叉反应    Human, Mouse, Rat, Dog, Cow, Horse, Rabbit,     

产品应用    WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500 （石蜡切片需做抗原修复） 
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.    

分 子 量    50kDa    

细胞定位    细胞核     

性    状    Lyophilized or Liquid    

浓    度    1mg/1ml    

免 疫 原    KLH conjugated synthetic peptide derived from human RUNX1 (150-190aa)    

亚    型    IgG    

纯化方法    affinity purified by Protein A    

储 存 液    0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Sodium azide    

保存条件    Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.    

急性髓细胞白血病1蛋白抗体产品介绍    background:
AML1/Runx1 binds DNA as a monomer and through the Runt domain. DNA binding is increased by heterodimerization with CBFB. Isoform AML1L can neither bind DNA nor heterodimerize and interferes with the transactivation activity of AML1/Runx1. CBF binds to the core site, 5'-PYGPYGGT-3', of a number of enhancers and promoters, including murine leukemia virus, polyomavirus enhancer, T cell receptor enhancers, LCK, IL3 and GMCSF promoters. The alpha subunit binds DNA and appears to have a role in the development of normal hematopoiesis. AML1/Runx1 is expressed in a wide variety of tissues and is expressed at the highest levels in thymus, bone marrow and peripheral blood. Defects in AML1/Runx1 are the cause of familial platelet disorder with associated myeloid malignancy, an autosomal dominant disease characterized by qualitative and quantitative platelet defects, and propensity to develop acute myelogenous leukemia。

Function:
CBF binds to the core site, 5'-PYGPYGGT-3', of a number of enhancers and promoters, including murine leukemia virus, polyomavirus enhancer, T-cell receptor enhancers, LCK, IL-3 and GM-CSF promoters. The alpha subunit binds DNA and appears to have a role in the development of normal hematopoiesis. Isoform AML-1L interferes with the transactivation activity of RUNX1. Acts synergistically with ELF4 to transactivate the IL-3 promoter and with ELF2 to transactivate the mouse BLK promoter. Inhibits KAT6B-dependent transcriptional activation.

Subunit:
Heterodimer with CBFB. RUNX1 binds DNA as a monomer and through the Runt domain. DNA-binding is increased by heterodimerization. Isoform AML-1L can neither bind DNA nor heterodimerize. Interacts with TLE1 and ALYREF/THOC4. Interacts with ELF1, ELF2 and SPI1. Interacts via its Runt domain with the ELF4 N-terminal region. Interaction with ELF2 isoform 2 (NERF-1a) may act to repress RUNX1-mediated transactivation. Interacts with KAT6A and KAT6B. Interacts with SUV39H1, leading to abrogation of transactivating and DNA-binding properties of RUNX1. Interacts with YAP1. Interacts with HIPK2 (By similarity). Interaction with CDK6 prevents myeloid differentiation, reducing its transcription transactivation activity.

Subcellular Location:
Nucleus.

Tissue Specificity:
Expressed in all tissues examined except brain and heart. Highest levels in thymus, bone marrow and peripheral blood.

Post-translational modifications:
Phosphorylated in its C-terminus upon IL-6 treatment. Phosphorylation enhances interaction with KAT6A. 
Methylated. 
Phosphorylated in Ser-249 Thr-273 and Ser-276 by HIPK2 when associated with CBFB and DNA. This phosphorylation promotes subsequent EP300 phosphorylation. 

DISEASE:
Note=A chromosomal aberration involving RUNX1/AML1 is a cause of chronic myelogenous leukemia (CML). Translocation t(3;21)(q26;q22) with EAP or MECOM. 
Note=A chromosomal aberration involving RUNX1/AML1 is found in childhood acute lymphoblastic leukemia (ALL). Translocation t(12;21)(p13;q22) with TEL. The translocation fuses the 3'-end of TEL to the alternate 5'-exon of AML-1H. 
Note=A chromosomal aberration involving RUNX1 is found in acute leukemia. Translocation t(11,21)(q13;q22) that forms a MACROD1-RUNX1 fusion protein. 
Defects in RUNX1 are the cause of familial platelet disorder with associated myeloid malignancy (FPDMM) [MIM:601399]. FPDMM is an autosomal dominant disease characterized by qualitative and quantitative platelet defects, and propensity to develop acute myelogenous leukemia. 
Note=A chromosomal aberration involving RUNX1/AML1 is found in therapy-related myeloid malignancies. Translocation t(16;21)(q24;q22) that forms a RUNX1-CBFA2T3 fusion protein. 
Note=A chromosomal aberration involving RUNX1/AML1 is a cause of chronic myelomonocytic leukemia. Inversion inv(21)(q21;q22) with USP16. 

Similarity:
Contains 1 Runt domain.

Database links:

Entrez Gene: 861 Human

Entrez Gene: 12394 Mouse

Entrez Gene: 50662 Rat

Omim: 151385 Human

SwissProt: Q01196 Human

SwissProt: Q03347 Mouse

SwissProt: Q63046 Rat

Unigene: 149261 Human

Unigene: 612648 Human

Unigene: 4081 Mouse

Unigene: 470227 Mouse

Unigene: 11201 Rat

Important Note:
This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.    

急性髓细胞白血病1蛋白抗体

hz-3359R Phospho-MARCKS (Ser162)  磷酸化丙氨酸蛋白激酶C底物Marcks抗体

hz-5500R Phospho-MARCKS(Ser170)  磷酸化丙氨酸蛋白激酶C底物Marcks抗体

hz-1595R MAD1  Mad1抗体

hz-0642R MAdCAM-1  粘膜血管定居因子抗体

hz-3859R MAGP2  纤微丝相关糖蛋白2抗体

hz-1975R DAXX  死亡相关蛋白6抗体(Fas死亡区相关蛋白)

hz-3135R Phospho-FADD(Ser191)  磷酸化Fas相关死亡结构域蛋白抗体

hz-5288R phospho-DAXX (Ser213)  磷酸化Fas相关死亡结构域蛋白抗体

hz-5291R phospho-DAXX (Ser495)  磷酸化Fas相关死亡结构域蛋白抗体

hz-5292R phospho-DAXX (Ser517)  磷酸化Fas相关死亡结构域蛋白抗体

hz-5293R phospho-DAXX (Ser671)  磷酸化Fas相关死亡结构域蛋白抗体

hz-0924R Mafa  v-maf 肌腱膜纤维肉瘤癌基因同源物A抗体

hz-2591R MAFbx/Fbx32  泛素蛋白连接酶抗体

hz-0257R MAG-a/b  髓鞘相关糖蛋白a/b抗体

hz-0258R MAG-a/L-MAG  髓鞘相关糖蛋白-a抗体

hz-0817R MAGE-1  黑色素瘤相关抗原抗体

hz-3645R MAGE-A4  黑色素瘤相关抗原4抗体

hz-3802R Mammaglobin A  乳腺珠蛋白1抗体

hz-3803R Mammaglobin B  乳腺珠蛋白2抗体

hz-2931R Mammaglobin A  乳腺珠蛋白1抗体

hzm-2028M Marijuana(2B1)  小鼠抗大麻单克隆抗体

hz-4053R MAVS  线粒体抗病毒信号MAVS蛋白抗体

hz-2340R 14-3-3E/YWHAE  14-3-3E蛋白抗体

hz-2076R Methamphetamine  甲基苯丙胺抗体

hzm-2068M Methamphetamine(4D2)  甲基苯丙胺单克隆抗体

hz-5141R MATR3/Matrin 3  核基质蛋白3抗体

hz-3636R MO25 alpha/CAB39  钙结合蛋白39抗体

hz-4054R Methionine adenosyltransferase  蛋氨酸腺苷转移酶抗体

hz-5590R phospho-YWHAE(Thr232)  磷酸化14-3-3E蛋白抗体

hz-2884R Mesothelioma  间质细胞蛋白抗体

hz-5084R ME1  胞浆苹果酸酶1抗体

hz-5424R MAP3K7IP3  NFKB激活蛋白1抗体

hz-3588R TORC1/CRTC1  环腺苷酸应答元件结合蛋白转录共激活因子TORC1抗体

hz-3453R Phospho-Torc1/Crtc1 (Ser151)  磷酸化CREB转录共激活因子TORC1抗体

hz-3591R MAP3K8/TPL2  丝裂原活化蛋白激酶激酶8抗体